Tumor Infiltrating Lymphocytes (TIL)

A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)

Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts

A Study of GC101 TIL in Advanced Solid Tumors (TR)

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

Study of GC101 TIL in Brain Glioma (Soochow2)

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer

Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma

Study on TIL for the Treatment of r/r Gynecologic Tumors

The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas

Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer

A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients